RxDoctor Payments Data

Jay Simhan, MD

Urology · Philadelphia, PANPI 1669613113

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (46.3%), consulting fees and education — rather than concentrated in one kind of arrangement. Coloplast accounts for 93.0% of it on its own, with 13 other manufacturers making up the rest. Among urology clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$110,169in general payments, 2019–2025

Across 236 payments — averaging $466.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$102K
  • Boston Scientific$7K
  • Medtronic$300
  • Procept Biorobotics Corporation$249
  • Innovation Technologies Inc$160
  • Endo Pharmaceuticals Inc.$150
  • plus $209 from 8 others
$27,804in research payments, 2019–2025

Across 3 payments — averaging $9268.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Coloplast$28K

What the payments were for

  • Consulting fees$22,80121%
  • Speaking & faculty fees$3,1503%
  • Grants$2,0002%
  • Travel & lodging$51,04346%
  • Food & beverage$8,4388%
  • Education$22,73721%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$110,169 in reported general payments places this provider in the 95th percentile of 596 urology providers in Pennsylvania.

See all urology providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$254,239
Medicare patients
333
Services billed
1,364

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →